Atlas Trials

Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction

Clinical trial NCT02070991 · COMPLETED

Trial details

NCT number
NCT02070991
Sponsor
Actelion
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Pulmonary Hypertension
Start date
2014-07-01
Primary completion
2015-11-01
Enrollment
63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.